Verily Shuts Down Its Medical Device Program as Alphabet Shifts Resources to AI

Alphabet's life sciences division, Verily, has laid off staff and eliminated its entire medical device program, according to Business Insider. CEO Stephen Gillett announced the “difficult decision” in a staff memo.

Gillett stated that Verily had built a legacy in developing world-class innovative medical devices but emphasized that “difficult decisions” were required as the company refocuses on AI and data infrastructure.

This move continues Alphabet’s strategy of aggressively investing in AI while cutting costs elsewhere. The company has conducted multiple rounds of layoffs in recent years, including cuts to its HR and cloud units in February and voluntary exit programs for its Platforms & Devices employees in spring.

Nodirbek Razzokov

Editor of «ZAMIN.UZ»